AccueilNEO • NASDAQ
add
NeoGenomics
12,64 $
Avant l'ouverture :(0,079 %)+0,0100
12,65 $
Fermé : 21 janv., 09:30:00 UTC−5 · USD · NASDAQ · Clause de non-responsabilité
Dernière clôture
12,64 $
Plage sur l'année
4,72 $ - 15,32 $
Capitalisation boursière
1,64 Md USD
Volume moyen
1,89 M
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
NASDAQ
Actualités des marchés
À propos
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
Date de fondation
2002
Siège social
Site Web
Employés
2 200